The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults
- PMID: 20026221
- PMCID: PMC2888809
- DOI: 10.1016/j.neuroimage.2009.12.046
The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults
Abstract
Abnormalities of the medial temporal lobe have been consistently demonstrated in schizophrenia. A common functional polymorphism, Val108/158Met, in the putative schizophrenia susceptibility gene, catechol-O-methyltransferase (COMT), has been shown to influence medial temporal lobe function. However, the effects of this polymorphism on volumes of medial temporal lobe structures, particularly in patients with schizophrenia, are less clear. Here we measured the effects of COMT Val108/158Met genotype on the volume of two regions within the medial temporal lobe, the amygdala and hippocampus, in patients with schizophrenia and healthy control subjects. We obtained MRI and genotype data for 98 schizophrenic patients and 114 matched controls. An automated atlas-based segmentation algorithm was used to generate volumetric measures of the amygdala and hippocampus. Regression analyses included COMT met allele load as an additive effect, and also controlled for age, intracranial volume, gender and acquisition site. Across patients and controls, each copy of the COMT met allele was associated on average with a 2.6% increase in right amygdala volume, a 3.8% increase in left amygdala volume and a 2.2% increase in right hippocampus volume. There were no effects of COMT genotype on volumes of the whole brain and prefrontal regions. Thus, the COMT Val108/158Met polymorphism was shown to influence medial temporal lobe volumes in a linear-additive manner, mirroring its effect on dopamine catabolism. Taken together with previous work, our data support a model in which lower COMT activity, and a resulting elevation in extracellular dopamine levels, stimulates growth of medial temporal lobe structures.
Copyright 2009 Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Sexually divergent effect of COMT Val/met genotype on subcortical volumes in schizophrenia.Brain Imaging Behav. 2018 Jun;12(3):829-836. doi: 10.1007/s11682-017-9748-1. Brain Imaging Behav. 2018. PMID: 28667376
-
Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test.Schizophr Bull. 2008 Nov;34(6):1231-9. doi: 10.1093/schbul/sbm155. Epub 2008 Jan 16. Schizophr Bull. 2008. PMID: 18199630 Free PMC article.
-
Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.Brain Res Mol Brain Res. 2004 Dec 6;132(1):51-6. doi: 10.1016/j.molbrainres.2004.09.005. Brain Res Mol Brain Res. 2004. PMID: 15548428
-
Catechol-O-methyl transferase and schizophrenia.Psychiatr Danub. 2010 Jun;22(2):270-4. Psychiatr Danub. 2010. PMID: 20562760 Review.
-
Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.CNS Drugs. 2007;21(7):535-57. doi: 10.2165/00023210-200721070-00002. CNS Drugs. 2007. PMID: 17579498 Review.
Cited by
-
COMT rs737865 mediates chemobrain in breast cancer patients with various levels of Ki-67.Am J Cancer Res. 2022 Jul 15;12(7):3185-3197. eCollection 2022. Am J Cancer Res. 2022. PMID: 35968333 Free PMC article.
-
Modulative effects of COMT haplotype on age-related associations with brain morphology.Hum Brain Mapp. 2016 Jun;37(6):2068-82. doi: 10.1002/hbm.23161. Epub 2016 Feb 27. Hum Brain Mapp. 2016. PMID: 26920810 Free PMC article.
-
COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation.J Psychiatry Neurosci. 2013 Nov;38(6):366-80. doi: 10.1503/jpn.120178. J Psychiatry Neurosci. 2013. PMID: 23527885 Free PMC article.
-
COMT Val158Met Polymorphism Influences the Cerebral Blood Flow Changes Related to Psychomotor Retardation in Major Depressive Disorder.Neuropsychiatr Dis Treat. 2022 Sep 25;18:2159-2169. doi: 10.2147/NDT.S379146. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36187559 Free PMC article.
-
Neurogenetics and pharmacology of learning, motivation, and cognition.Neuropsychopharmacology. 2011 Jan;36(1):133-52. doi: 10.1038/npp.2010.96. Epub 2010 Jul 14. Neuropsychopharmacology. 2011. PMID: 20631684 Free PMC article. Review.
References
-
- Abi-Dargham A, Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist. 2003;9:404–416. - PubMed
-
- Andreasen NC. Scale for the Assessment of Negativ Symptoms (SANS) University of Iowa; Iowa City: 1983.
-
- Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS) University of Iowa; Iowa City: 1984.
-
- Andreasen NC. Psychiatric Symptoms You Currently Have—Baseline (PSYCH-BASE) The University of Iowa; Iowa City, Iowa: 1987.
-
- Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry. 1992;49:615–623. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous